Chem. Abstract Caplus DN 120:323604 RN# 155009-95-3 Yokota Sumio et al, Jan. 1994.* |
Chem. Abstract Caplus 107:236509 RN# 111577-09-4 Takematsu et al, Feb. 1987.* |
Chem. abstract Caplus 83:2075 RN 55218 -93-4 Lawake Dwane et al, 1974.* |
Mabile et al., “Tocopherol and Trolox Block the Early Intracellular Events (TBARS and Calcium Rises) Elicted by Oxidized Low Density Liproteins in Cultured Endothelial Cells”, Free Radical Biology & Medicine, vol. 19 No. 2, pp. 177-187, (1995). |
Agarwal et al., “Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL” American Journal Physiological, vol. 271, pp. 814-823, (1996). |
Drukker et al., “Failure of Antioxidant Therapy to Attenuate Interstitial Disease in Rats with Reversible Nephrotic Syndrome”, Journal of the American Society of Nephrology, vol. 9, , pp. 243-251, (1998). |
Lee et al., “Dietary antioxidant inhibits lipropotein oxidation and renal injury in experimental focal segmental glomerulosclerosis”, Kidney International, vol. 51, pp. 1151-1159, (1997). |
Hirano et al., “The Lowering Effect of Probucol on Plasma Lipoprotein and Proteinuria in Puromycin Aminonucleoside-Induced Nephrotic Rats”, Nephron, vol. 58, pp. 95-100, (1991). |
Thakur et al., “Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria”, Kidney International, vol. 34, pp. 494-499, (1988). |
Paller et al., “Oxygen Free Radicals in Ischemic Acute Renal Failure in the Rat”, J. Clin. Invest., vol. 74 pp. 1156-1164, (1984). |
Rehan et al., “Evidence for the Role of Oxygen Radicals in Acute Nephrotoxic Nephritis”, Lab. Invest. vol. 51, No. 4, pp. 396-403, (1984). |
Modi et al., “Effects of probucol in renal function and structure in rats with subtotal kidney ablation” J. Lab. Clin. Med., vol. 120, No. 2, pp. 310-317, (1992). |
Van Den Branden et al., “Effect of Vitamin E on Antioxidant Enzymes, Lipids Peroxidation Products and Glomerulosclerosis in the Rat Remnant Kidney”, Nephron, vol. 76, pp. 77-81, (1997). |
Konya et al., “Lack of effect of antioxidant therapy during renal ischemia and reperfusion in dogs”, Experientia, vol. 49, pp. 235-237, (1993). |
Holding et al., “Failure of a 21-Aminosteroid Antioxidant to Ameliorate Cisplatin-Induced Nephrotoxicity” Human & Experimental Toxicology, vol. 10, pp. 323-326, (1991). |
Hammond et al, “2,3-Dihydro-5-benzofuranols as Antioxidant-Based Inhibitors of Leukotriene Biosynthesis”, Journal of Medicinal Chemistry, 1989, vol. 32, No. 5, pp. 1006-1020. |
Hammond et al, “Antioxidant-Based Inhibitors of Leukotriene Biosynthesis. The Discovery of 6-[1-[2-(Hydroxymethyl)phenyl]-1-propen-3-yl]-2, 3-dihydro-5-benzofuranol, a Potent Topical Antiinflammatory Agent”, Journal of Medicinal Chemistry, 1990, vol. 33, No. 3, pp. 908-918. |
Fujimoto et al, “New alkyl-hydroxy-benzofuran derivative lipoxidase inhibit useful allergic inflammation bronchial asthma rheumatism disease psoriasis”, WPI World Patent Information Derwent, vol. 51, No. 52, XP002009524. |